Skip to main content
. 2021 Jul 12;40:227. doi: 10.1186/s13046-021-02029-y

Fig. 9.

Fig. 9

Deficiency of circ_0084615 suppressed tumor formation in vivo. (A-C) Tumor volume and tumor weight were examined. (D) The levels of ONECUT2, ZEB2, E-cadherin, Vimentin and VEGFA in xenograft tumors were examined with IHC assay. ***P < 0.001